These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 31750728)

  • 1. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
    Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
    Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
    [No Abstract]   [Full Text] [Related]  

  • 2. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis.
    Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X
    J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
    Yin H; Cui X
    Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
    [No Abstract]   [Full Text] [Related]  

  • 5. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway.
    Wang B; Wang K; Jin T; Xu Q; He Y; Cui B; Wang Y
    Biomed Pharmacother; 2020 Sep; 129():110395. PubMed ID: 32887025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/
    Han C; Wang S; Wang H; Zhang J
    Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821
    [No Abstract]   [Full Text] [Related]  

  • 7. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
    Deng Y; Zhu H; Xiao L; Liu C; Meng X
    Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.
    Hua L; Huang L; Zhang X; Feng H
    J Biosci; 2020; 45():. PubMed ID: 32975228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
    Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
    J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
    J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
    Li H; Jia Y; Cheng J; Liu G; Song F
    Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for hypoxia
    Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
    Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression.
    Wu Y; Yao Y; Yun Y; Wang M; Zhu R
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
    Ding H; Cui L; Wang C
    Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.
    Gao K; Wang T; Qiao Y; Cui B
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):979-987. PubMed ID: 34110366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.